BBA//Fjeldco advises Arctic Therapeutics on EUR 26.5M Series A financing
The BBA//Fjeldco team congratulates Arctic Therapeutics on the successful closing of their €26.5M oversubscribed Series A financing. This significant milestone will help propel the company's groundbreaking treatments for dementia and inflammatory skin diseases further into clinical development.
Another shining example of Icelandic innovation, BBA//Fjeldco is proud to support Arctic Therapeutics in their mission of addressing critical unmet medical needs and improving lives worldwide and it will be exciting to watch the next chapter in the company's development.
Congratulations again to Arctic Therapeutics on a successful financing.
The BBA//Fjeldco team congratulates Arctic Therapeutics on the successful closing of their €26.5M oversubscribed Series A financing. This significant milestone will help propel the company's groundbreaking treatments for dementia and inflammatory skin diseases further into clinical development.
Another shining example of Icelandic innovation, BBA//Fjeldco is proud to support Arctic Therapeutics in their mission of addressing critical unmet medical needs and improving lives worldwide and it will be exciting to watch the next chapter in the company's development.
Congratulations again to Arctic Therapeutics on a successful financing.
The BBA//Fjeldco team congratulates Arctic Therapeutics on the successful closing of their €26.5M oversubscribed Series A financing. This significant milestone will help propel the company's groundbreaking treatments for dementia and inflammatory skin diseases further into clinical development.
Another shining example of Icelandic innovation, BBA//Fjeldco is proud to support Arctic Therapeutics in their mission of addressing critical unmet medical needs and improving lives worldwide and it will be exciting to watch the next chapter in the company's development.
Congratulations again to Arctic Therapeutics on a successful financing.